Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Intersect ENT, Inc. | d470105dex321.htm |
| EX-31.2 - EX-31.2 - Intersect ENT, Inc. | d470105dex312.htm |
| EX-31.1 - EX-31.1 - Intersect ENT, Inc. | d470105dex311.htm |
| 10-K - FORM 10-K - Intersect ENT, Inc. | d470105d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following registration statements:
| (1) | Registration Statement (Form S-8 No. 333-197885) pertaining to the 2003, 2013 and 2014 Equity Incentive Plans and 2014 Employee Stock Purchase Plan of Intersect ENT, Inc.; |
| (2) | Registration Statement (Form S-8 No. 333-202670) pertaining to the 2014 Equity Incentive Plan and 2014 Employee Stock Purchase Plan of Intersect ENT, Inc.; |
| (3) | Registration Statement (Form S-8 No. 333-209713) pertaining to the 2014 Equity Incentive Plan of Intersect ENT, Inc.; and |
| (4) | Registration Statement (Form S-8 No. 333-216319) pertaining to the 2014 Equity Incentive Plan of Intersect ENT, Inc. |
of our reports dated February 28, 2018, with respect to the financial statements and schedule of Intersect ENT, Inc., and the effectiveness of internal control over financial reporting of Intersect ENT, Inc. included in this Annual Report (Form 10-K) of Intersect ENT, Inc. for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Redwood City, California
February 28, 2018